Wenrong Huang Selected Research

Wenrong Huang Research Topics

Disease

7	Neoplasms (Cancer) 11/2023 - 06/2013
5	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 01/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2019 - 02/2015
3	Lymphoma (Lymphomas) 11/2023 - 01/2023
3	Bronchiolitis Obliterans Syndrome 02/2021 - 02/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2023 - 05/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 08/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2018 - 01/2014
2	Neutropenia 01/2018 - 01/2015
1	Pain (Aches) 11/2023
1	Hemorrhage 02/2022
1	Thrombocytopenia (Thrombopenia) 02/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Fever (Fevers) 03/2016
1	Bacteremia 03/2016
1	Febrile Neutropenia 03/2016
1	Hematologic Diseases (Blood Diseases) 01/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2014
1	Philadelphia Chromosome 01/2014
1	Mycoses (Diseases, Fungus) 06/2013
1	Invasive Fungal Infections 06/2013
1	Multiple Myeloma 12/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2011

Drug/Important Bio-Agent (IBA)

3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2021 - 02/2015
2	thymoglobulin FDA Link 02/2021 - 02/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2019 - 01/2019
1	orelabrutinibIBA 11/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	eltrombopag FDA Link 02/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2021
1	Methotrexate (Mexate)FDA LinkGeneric 02/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2019
1	AclarubicinIBA 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Decitabine FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	AntigensIBA 10/2017
1	CytokinesIBA 08/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2016
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2016
1	Inosine Monophosphate (IMP)IBA 03/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2016
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 03/2016
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2015
1	Caspofungin (Cancidas)FDA Link 01/2015
1	Voriconazole (Vfend)FDA LinkGeneric 01/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Sodium Glutamate (Accent)IBA 06/2013
1	Melphalan (Alkeran)FDA LinkGeneric 12/2012
1	Bortezomib (Velcade)FDA Link 12/2012

Therapy/Procedure

8	Hematopoietic Stem Cell Transplantation 11/2023 - 01/2014
8	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2022 - 04/2011
6	Therapeutics 11/2023 - 12/2012
5	Stem Cell Transplantation 01/2023 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
2	Transplantation 01/2014 - 06/2012
1	Induction Chemotherapy 01/2019
1	Cell Transplantation 06/2018
1	Salvage Therapy 01/2018
1	Organ Transplantation 01/2014
1	Chemoradiotherapy 09/2011